Text Size

Treatment of Late Abortion: Evacuatio Uteri or Conservative Treatment

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2005 by Rigshospitalet, Denmark.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Rigshospitalet, Denmark
ClinicalTrials.gov Identifier:
NCT00256009
First received: November 18, 2005
Last updated: May 31, 2006
Last verified: November 2005
History of Changes
  Purpose

A randomize trial: expectation or evacuatio uteri for the treatment after late abortion


Condition Intervention Phase
Abortion, Spontaneous
Abortion, Induced
 Drug: Cytotec
 Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Evacuatio Uteri or Conservtive Treatment After Late Abortion. A Randomize Trial.

Resource links provided by NLM:

MedlinePlus related topics: Miscarriage
Drug Information available for: Misoprostol
U.S. FDA Resources

Further study details as provided by Rigshospitalet, Denmark:

Primary Outcome Measures:
  • Side-effect
  • Complication

Secondary Outcome Measures:
  • Quality of life

Estimated Enrollment: 200
Estimated Study Completion Date: January 2009
Detailed Description:

A randomize trial adressing 200 women consecutively recruited from clinical practice at Rigshospitalet.Expectation: administration of 800 microgram Cytotec half an hour after delivery. Surgery: Evacuation of the uterus

  Eligibility

Ages Eligible for Study:   18 Years to 60 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

abortion at gestational age (ultrasound) 14+0 - 20+0

Exclusion Criteria:

Allergy to cytotec

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00256009

Contacts
Contact: Lars Alling Møller, Md phd 0045 35451338 Lars.Alling@rh.dk

Sponsors and Collaborators
Rigshospitalet, Denmark
Investigators
Principal Investigator: Lars Alling Møller, MD phd Rigshospitalet, Denmark
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00256009     History of Changes
Other Study ID Numbers: KF 01 279545
Study First Received: November 18, 2005
Last Updated: May 31, 2006
Health Authority: Denmark: National Board of Health

Keywords provided by Rigshospitalet, Denmark:
Late abortion

Additional relevant MeSH terms:
Abortion, Spontaneous
Pregnancy Complications
Misoprostol
Anti-Ulcer Agents
Gastrointestinal Agents
Therapeutic Uses
 Pharmacologic Actions
Oxytocics
Reproductive Control Agents
Physiological Effects of Drugs
Abortifacient Agents, Nonsteroidal
Abortifacient Agents

ClinicalTrials.gov processed this record on May 21, 2013